pp32r1 controls the decay of the RNA-binding protein HuR

Imamachi,Kenji; Higashino,Fumihiro; Kitamura,Tetsuya; Kakuguchi,Wataru; Yanagawa-Matsuda,Aya; Ishikawa,Makoto; Kitagawa,Yoshimasa; Totsuka,Yasunori; Shindoh,Masanobu

doi:10.3892/or.2013.2956

2014-March Volume 31 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

2014-March Volume 31 Issue 3

Full Size Image

Article

pp32r1 controls the decay of the RNA-binding protein HuR

Authors:
- Kenji Imamachi
- Fumihiro Higashino
- Tetsuya Kitamura
- Wataru Kakuguchi
- Aya Yanagawa-Matsuda
- Makoto Ishikawa
- Yoshimasa Kitagawa
- Yasunori Totsuka
- Masanobu Shindoh
View Affiliations / Copyright

Affiliations: Department of Oral Pathology and Biology, Hokkaido University Graduate School of Dental Medicine, Sapporo 060-8586, Japan, Department of Oral and Maxillofacial Surgery, Hokkaido University Graduate School of Dental Medicine, Sapporo 060-8586, Japan, Department of Oral Diagnosis and Medicine, Hokkaido University Graduate School of Dental Medicine, Sapporo 060-8586, Japan
Pages: 1103-1108
|
Published online on: December 31, 2013

https://doi.org/10.3892/or.2013.2956
Expand metrics +

Abstract

pp32 is a tumor suppressor and is one of the associated proteins of the RNA-binding protein HuR. The pp32-HuR complex is exported to the cytoplasm of cells under stress conditions, and HuR is degraded by caspases in the cytoplasm. In the present study, we examined the role of pp32r1, a member of the pp32 family that has oncogenic properties, in the decay of HuR. pp32r1 was found to be abundantly expressed in cancer cells, and overexpression of pp32r1 induced colony formation in soft-agar. pp32r1 was expressed in both the nucleus and cytoplasm, whereas pp32 was predominantly localized in the nucleus. Even with lethal stress such as staurosporine (STS), HuR in the cytoplasm was never downregulated, and caspase-3 activity was inhibited when cells expressed pp32r1. pp32r1 bound to HuR without interacting with pp32. In cancer cells, HuR survived in the cytoplasm of cells overexpressing pp32r1, although HuR was not expressed in the cytoplasm of pp32-expressing cells, similar to lethal stress conditions. Taken together, these results indicate that pp32r1 binds to HuR to avoid the caspase-mediated decay of HuR in the cytoplasm of cells. We suggest that this function contributes to the oncogenic activity of pp32r1.

View Figures

View References

1	Matsuoka K, Taoka M, Satozawa N, et al: A nuclear factor containing the leucine-rich repeats expressed in murine cerebellar neurons. Proc Natl Acad Sci USA. 91:9670–9674. 1994. View Article : Google Scholar : PubMed/NCBI
2	Chen TH, Brody JR, Romantsev FE, et al: Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci. Mol Biol Cell. 12:2045–2056. 1996. View Article : Google Scholar : PubMed/NCBI
3	Kadkol SS, Brody JR, Pevsner J, Bai J and Pasternack GR: Modulation of oncogenic potential by alternative gene use in human prostate cancer. Nat Med. 5:275–279. 1999. View Article : Google Scholar
4	Kadkol SS, El Naga GA, Brody JR, et al: Expression of pp32 gene family members in breast cancer. Breast Cancer Res Treat. 68:65–73. 2001. View Article : Google Scholar : PubMed/NCBI
5	Pan W, da Graca LS, Shao Y, Yin Q, Wu H and Jiang X: PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis. J Biol Chem. 284:6946–6954. 2009. View Article : Google Scholar : PubMed/NCBI
6	Adegbola O and Pasternack G: Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. J Biol Chem. 280:15497–15502. 2005. View Article : Google Scholar : PubMed/NCBI
7	Matilla A, Koshy BT, Cummings CJ, Isobe T, Orr HT and Zoghbi HY: The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature. 389:974–978. 1997. View Article : Google Scholar : PubMed/NCBI
8	Beresford PJ, Kam CM, Powers JC and Lieberman J: Recombinant human granzyme A binds to two putative HLA-associated proteins and cleaves one of them. Proc Natl Acad Sci USA. 94:9285–9290. 1997. View Article : Google Scholar : PubMed/NCBI
9	Brennan CM, Gallouzi IE and Steitz JA: Protein ligands to HuR modulate its interaction with target mRNA in vivo. J Cell Biol. 151:1–14. 2000. View Article : Google Scholar : PubMed/NCBI
10	Gallouzi IE, Brennan CM and Steitz JA: Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. RNA. 7:1348–1361. 2001. View Article : Google Scholar
11	Ma WJ, Cheng S, Campbell C, Wright A and Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem. 99:8144–8151. 1996.PubMed/NCBI
12	Hinman MN and Lou H: Diverse molecular functions of Hu proteins. Cell Mol Life Sci. 65:3168–3181. 2008. View Article : Google Scholar : PubMed/NCBI
13	Lopez de Silanes I, Lal A and Gorospe M: HuR: post-transcriptional paths to malignancy. RNA Biol. 2:11–13. 2005.PubMed/NCBI
14	López de Silanes I, Fan J, Yang X, et al: Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene. 22:7146–7154. 2003.PubMed/NCBI
15	Srikantan S and Gorospe M: HuR function in disease. Front Biosci. 17:189–205. 2012. View Article : Google Scholar
16	Higashino F, Aoyagi M, Takahashi A, et al: Adenovirus E4orf6 targets pp32/LANP to control the fate of ARE-containing mRNA by perturbing the CRM1-dependent mechanism. J Cell Biol. 170:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
17	Kuroshima T, Aoyagi M, Yasuda M, et al: Viral-mediated stabilization of AU-rich element containing mRNA contributes to cell transformation. Oncogene. 30:2912–2920. 2011. View Article : Google Scholar : PubMed/NCBI
18	Hasegawa H, Kakuguchi W, Kuroshima T, et al: HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells. Br J Cancer. 100:1943–1948. 2009. View Article : Google Scholar : PubMed/NCBI
19	Kakuguchi W, Kitamura T, Kuroshima T, et al: HuR knockdown changes the oncogenic potential of oral cancer cells. Mol Cancer Res. 8:520–528. 2010. View Article : Google Scholar : PubMed/NCBI
20	Mazroui R, Di Marco S, Clair E, et al: Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J Cell Biol. 180:113–127. 2008. View Article : Google Scholar : PubMed/NCBI
21	Weigel S and Dobbelstein M: The nuclear export signal within the E4orf6 protein of adenovirus type 5 supports virus replication and cytoplasmic accumulation of viral mRNA. J Virol. 74:764–772. 2000. View Article : Google Scholar : PubMed/NCBI
22	Aoyagi M, Higashino F, Yasuda M, et al: Nuclear export of the adenovirus E4orf6 protein is necessary for its ability to antagonize the apoptotic activity of the BH3-only proteins. Oncogene. 22:6919–6927. 2003. View Article : Google Scholar : PubMed/NCBI
23	Higashino F, Pipas JM and Shenk T: Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proc Natl Acad Sci USA. 95:15683–15687. 1998. View Article : Google Scholar : PubMed/NCBI
24	Buddaseth S, Göttmann W, Blasczyk R, et al: Dysregulation of cell cycle caused by overexpression of the oncogene pp32r1 (ANP32C) and the Tyr>His mutant pp32r1Y140H. Biochim Biophys Acta. 1833:1212–1221. 2013. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

pp32r1 controls the decay of the RNA-binding protein HuR

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles